• Medical devices: Acronyms/Abbreviations

    The medical devices industtry is full of Acronyps/Abbreviations and many a times we struggle to find which one is which, so following is the list of some of them that you may like to refer:

    DDP                     Distinct Dose Pen 

  • Messe Frankfurt India announces Medical Device Innovation Summit to address growing demand for specialised medical equipment

    As the nation continues its battle against Covid-19, together with the healthcare workers on the frontline, the pharma and medical device industries have been actively playing a crucial role and strengthening efforts to ensure best healthcare services and medical equipments. With India standing as the most prominent destination for medical tourism as well as a leading player in the global pharmaceuticals industry, demand for specialized, high-tech medical equipment is expected to surge.
  • Plastic Ampoule Configurations and Materials of Composition

    Technical data sheets are available for both our polyethylene blend and polypropylene blend versions. Plastic Ampoules can be fluorinated at a number of different intensity levels. The fluorination process may enhance many Plastic Ampoule properties, including chemical resistance. For the dropper tip, the precision dropper is composed of polyethylene. James Alexander’s standard swab applicator tip is composed of polyolefin. A variety of swab and foam applicator tips are available for different applications.

  • Airnov laser-marked desiccant canisters reduced risk of contamination by eliminating print or paper labels

    August 24, 2020 – Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, is introducing a new line of laser-marked sorbent and desiccant canisters without direct printing or labeling. Laser marking produces clean, readable product and warning information with reduced risk of contamination of packaged pharmaceuticals and nutraceuticals. It also contributes to a smaller carbon footprint. Laser marking utilizes the energy of a highly focused laser beam to produce a combined thermal and photochemical effect that results in permanent marking. Airnov has integrated the lasers on its 1-gram canister lines, with the ability to mark on both sides and without sacrificing the high-speed throughput Airnov is known for. Today’s lasers are high-speed and capable of rendering highly detailed, precise imagery and text, and by marking both sides Airnov can include all industry-required symbols and information such as “DO NOT EAT” in multiple languages. “The pharmaceutical packaging and nutraceutical packaging markets continue to demand a higher level of safety,” says Nicolas Martinez, global product line manager. “We have responded by eliminating extraneous materials like inks, paper and adhesives from the packaging system and offering a much purer replacement.” The 1-gram drop-in-style canisters are the same size as standard printed and labeled canisters and provide the same protection against chemical or physical drug degradation due to moisture. The canisters are molded in white to facilitate laser marking. The colorant used is the same, GRAS material used in bottles throughout the pharmaceutical industry. By eliminating the external supply chain required for inks and labels, laser marking reduces the environmental impact by eliminating the associated transportation, packaging, and waste streams. It also reduces time-to-market for non-standard, custom markings. Dr. Matthias Brommer, Managing Director & CEO, adds, “Laser-marking of canisters represents one of the first innovations launched under our new Airnov brand, and exemplifies our commitment to technology development targeted at satisfying evolving customer demands.” MEDIA RELEASE Airnov Healthcare Packaging – 24/08/2020 2 Ideal for insertion into pharmaceutical and nutraceutical product packaging, canisters can be filled with silica gel for moisture adsorption, activated carbon canisters for odor control, and 2-in-1 canisters deliver moisture and odor control in one unit. Airnov canisters are fully compliant with US FDA and EU regulations for use in pharmaceutical applications and comply with US Pharmacopeia USP <670> standard for pharmaceutical desiccants. A popular and cost-efficient alternative to desiccant packets, which are supplied on reels and must be cut apart before insertion, the rigid canister construction facilitates continuous hopper feeding and high-speed automatic insertion on standard insertion equipment. 

  • Finally! A ‘Smart Packaging’ Solution for Poor Medication Adherence

    There are many factors that contribute to low adherence, such as poor communication between doctors and patients and unwanted side effects. But according to ExpressScripts, 69% of nonadherence is behavioral, caused by forgetfulness or procrastination. Low adherence is a pain point for Pharma Clearly, these numbers are very concerning in terms of negative patient health outcomes, but what does this mean for the pharmaceutical industry? Pharma companies are losing hundreds of billions of dollars every year due to non-adherence.

  • EMI PROTECTION FILMS FROM SCHREINER PROTECH REDUCE DAMAGE CAUSED BY ELECTROMAGNETIC WAVES

    In the event of inadequate shielding, electromagnetic waves and electrostatic fields cause unwanted voltages and currents resulting in mutual interferences of neighboring equipment. The consequences are audible humming, functional impairments and signal interferences (e.g. of sensors and electronic control units), plus a higher risk of fire due to overloads up to and including total equipment failure. Protection films for EMI shielding from Schreiner ProTech provide relief: They reduce the hazards emanating from electromagnetic radiation. The films consist of electrically conductive materials such as metallized films, metal foils, metallized foam and metal fabrics. The frequency of the radiation is an important factor in selecting the shielding film: the lower the frequency, the larger the wavelength and penetration depth of the radiation. The film’s shielding effect depends on the material’s properties, the geometry and the assembly conditions. All films are optimized to suit the customer’s specific application. Customers test the shielding in real-world conditions at their own sites. Electromagnetic compatibility (EMC) refers to a technical device’s ability of not interfering with other devices due to unwanted electrical or electromagnetic effects and not to be interfered with by other devices. Electromagnetic interference (EMI) refers to effects on the functionality of electrical circuits, devices and systems caused by magnetic and electrical fields. Full-Service Package Schreiner ProTech offers an extensive range of modified processing systems supporting the application of EMI protection films. They can be customized to suit specific requirements. As a result, the customer receives a total solution from a one-stop shop in which the individual components are optimally.

  • Specialty Label from Schreiner MediPharm Blinds Vials for Clinical Trial Conducted by CSL Behring

    Flexi-Cap and Booklet-Label for Clinical Research

    Oberschleissheim, August 12, 2020 – For an international Phase III study of a new immunoglobolin, CSL Behring relies on a novel label combination from Schreiner MediPharm: With a special Flexi-Cap version that completely covers the vial and a Booklet-Label for multilingual product information, the vials containing the drugs to be tested are reliably blinded.

     

  • Continuing Sustainability Efforts, Neopac Moves Toward Mono-Material Barrier Tubes Designed for Recyclability

    Neopac’s goal is to create tubes that simplify recycling–a crucial aspect of next-level sustainability practices. The EU has announced elevated targets for plastic packaging recyclability, aiming for 50% by 2025 and 55% by 2030. Other geographic areas have introduced similar targets, challenging packaging manufacturers to utilize innovative materials and embrace leaner production and logistics initiatives. Meeting these targets will require increased cooperation between all actors involved in the life cycles of plastics. Over the long term, modernizing and harmonizing systems for waste management is inevitable; in the nearer term, however, eco-minded advancements in the ways plastics are designed and produced are a must. Need for mono-materials Multi-layer aluminum-barrier packaging is particularly problematic for recyclers as, among other challenges, it is incompatible with mechanical sorting techniques. Because of this, each year packaging comprised of multi-material plastics causes one million tons of waste in Europe alone. Neopac’s push for mono-material tubes will employ sound packaging science to align with current recycling practices and processes, while providing its cosmetics, food and pharma customers with strong barrier properties to protect sensitive products. Slated for market launch later this year, the new portfolio of tubes, called Polyfoil® MMB (mono-material barrier) will be almost entirely polyethylene (PE) based, containing less that 5% of foreign materials (inks, adhesives, etc.) to avoid disruptions in existing recycling processes. Neopac is aiming to spearhead the application of new barrier technologies, including highly oriented PE barrier films (MDO), thin film ethylene vinyl alcohol (EVOH) layers, barrier lacquers and ceramic barrier films. In addition to product protection, the Polyfoil® MMB tubes will offer broad options for appealing aesthetics. Notably, the tubes will incorporate metallized tube body options owing to an ultra-thin “sandwich layer” that, in terms of recyclability, is widely accepted. White and transparent versions also will be available. Due to the reduced overall wall thickness, the lightweight tubes will offer as much as 40% tube body weight reduction compared to standard Polyfoil® tubes with aluminum barriers while keeping very similar haptics. Neopac also is currently conducting tests to convert caps from PP to PE, which is another goal being explored for the near future. “The push for enhanced recyclability is undeniable, with nearly 9 in 10 Europeans worried about the impact of plastics on the environment while only 5% of plastic materials are currently being reused,” said Martina Christiansen, Director Sales Tubes Neopac. “Technology must play a role in meeting higher recycling standards, and mono-material barrier tubes will represent a sizable step forward in packaging science.” Neopac has consistently focused on the packaging sustainability movement. The company recently released a Tube Design Guide for Recyclability. The company also offers an EcoDesign portfolio, primarily for cosmetics and personal care applications, that includes: • Recycled Tube featuring 75% recycled, “food-grade light” compliant polyethylene plastics; • Sugarcane Tube, made from renewable raw materials and offering the same characteristics and processability as fossil-based polyethylene; • and PICEA™ Tube, comprised of 95% renewable material in the tube body and shoulder–including 10% of spruce wood from wood waste in sawmills.
  • Marchesini Group, consolidated turnover of 441 million Euro. Three new companies acquired in the mechanical and automation supply chain

    Pianoro (Bologna) – Marchesini Group closed 2019 with a consolidated turnover of 441 million Euro, a repeat of the excellent performance in 2018. During the current year, the Marchesini Group has continued its production activities as steadily as possible, despite the sharp slowdown in the Italian and international economy caused by the Covid-19 pandemic. Notably, between February and June more than 50 virtual tests were carried out, which made it possible to respect the machine delivery times and maintain a stable economic outlook for the company.
  • How patient preferences are changing the design of drug delivery devices

    The following insights detail which preferences are driving the evolution of drug delivery device design. Adding ease to applications From using implants for contraception, to getting insulin injections at the dinner table, to using a wearable device to administer chemotherapy in the comfort of home, applications for drug delivery are largely being driven by patient preferences. Not only do these growing number of applications improve the patient experience, they also empower patients to play a more active role in managing their medications.2 Key takeaway: Drug delivery devices are increasingly designed to make compliance easier for patients, including new applications to help patients manage their medications on their own terms. Offering more flexibility in autoinjectors Produced by the millions, pens and autoinjectorscontinue to evolve due to a variety of factors, including the emergence of new biologics that require strict specifications for packaging and delivery. At the same time, patients are seeking more options to self-administer medications on a less-frequent basis, which is driving a wider variety of treatment options and releasing formulators from having to conform to <1mL dosage requirements.2 Key takeaway: Even in the well-defined pen and autoinjector market, we are seeing greater demand for ready-to-use drug delivery solutions that work with the latest biologic medications. Controlling where and when drugs are administered Even though prefilled syringe systems are still a primary packaging option, there is increasing demand for cartridge-based systems as dosage volumes increase and more patients administer their own medications. Using a prefilled, cartridge-based system empowers patients to take greater control by managing more of their care at a time and place that works for them, such as at home instead of a hospital.2 Key takeaway: Patients are looking for flexibility when it comes to larger-sized doses, making packaging of prefilled cartridges an increasingly popular option for drugs that require doses up to 10mL. Using technology to improve compliance Intelligent, wearable delivery systems offer another advantage for patients looking for more freedom and flexibility in their drug regimen. These devices use a smartphone connection to track and report injections to healthcare providers, sending helpful reminders to patients and alerts to their doctors when doses are missed. Wearable devices also offer other advantages over traditional autoinjectors, including greater flexibility to modify dosing and delivery times, as well as the ability to monitor patient adherence.1 Key takeaway: Packaging for drug delivery devices is becoming more user-centric, using technology to help patients minimize risk, improve compliance and support better health outcomes. Taking a holistic approach to drug delivery design As patients become more involved in managing their treatment plans and administering their medications, manufacturers are responding by applying human-centered design principles to injectables. Patients are demanding devices that are reliable and easy to use, with instructions that are easy to understand and applications that are as pain-free as possible.1 This more holistic approach helps to ensure the medication, device and patient experience work in harmony to support the drug delivery goals of patients and providers. Whether your project requires a single machine or a complex, large-scale integration, you need a partner with deep industry experience to help you increase patient safety while meeting FDA regulations. Let MGS solve your toughest challenges. We'll deliver a comprehensive solution that optimizes your production while minimizing your risk. Contact us at info@mgsmachine.com or request more information below.

  • Pages